A new study has found that reduced glutathione, when combined with entecavir, significantly improves liver function, reduces fibrosis, and enhances HBV-DNA clearance in chronic hepatitis B patients.

To tackle the ongoing high burden of hepatitis C virus (HCV) infections among people who inject drugs (PWID), WHO has set a specific incidence target among PWID of no more than two new infections per ...

The award recognizes UB work that leveraged facilitated telemedicine to cure hepatitis C in 90% of people with opioid use disorder.

A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...

A novel approach developed by a UB physician-scientist and colleagues to cure hepatitis C virus in people with opioid use ...

This expansion is part of the NHS Blood Borne Virus (BBV) opt-out testing programme, which will now include an additional 30 ...

Some people may remain ill after COVID infection because the virus still lurks in their bodies. The looming question now is: ...

The Kaiser Permanente Hawaii Viral Hepatitis Clinic reached a milestone by curing its 1,000th patient of hepatitis C. “It’s a very satisfying thing to make that call and tell someone they’re cured,” ...

HONOLULU (HawaiiNewsNow) - Hawaii’s Kaiser Permanente Viral Hepatitis Clinic has reached a major milestone toward combative ...

The manuscript addresses the 3D chromatin architecture in monocytes from patients with alcohol-associated hepatitis and its relationship to enhanced transcription of innate immune genes. While the ...

Considered once to be a lifelong disease, Hepatitis C has now been treated and cured in 1,000 patients at Kaiser Permanente.